7 T Magnetic Resonance Spectroscopic Imaging in Multiple Sclerosis: How Does Spatial Resolution Affect the Detectability of Metabolic Changes in Brain Lesions?
暂无分享,去创建一个
H. Lassmann | F. Leutmezer | S. Trattnig | W. Bogner | M. Považan | S. Gruber | A. Dal-Bianco | P. Bednařík | P. Rommer | E. Hečková | Bernhard Strasser | G. Hangel
[1] F. Barkhof,et al. Metabolites predict lesion formation and severity in relapsing-remitting multiple sclerosis , 2018, Multiple sclerosis.
[2] Wolfgang Bogner,et al. Ultra-high resolution brain metabolite mapping at 7 T by short-TR Hadamard-encoded FID-MRSI , 2016, NeuroImage.
[3] R. Edden,et al. Reduced GABA levels correlate with cognitive impairment in patients with relapsing-remitting multiple sclerosis , 2018, European Radiology.
[4] Wolfgang Bogner,et al. Mapping an Extended Neurochemical Profile at 3 and 7 T Using Accelerated High-Resolution Proton Magnetic Resonance Spectroscopic Imaging , 2017, Investigative radiology.
[5] Shu Liu,et al. Proton MR spectroscopy of lesion evolution in multiple sclerosis: Steady‐state metabolism and its relationship to conventional imaging , 2017, Human brain mapping.
[6] Susan A Gauthier,et al. MRI in the assessment and monitoring of multiple sclerosis: an update on best practice , 2017, Therapeutic advances in neurological disorders.
[7] Yong Yang,et al. Metabolic changes in normal appearing white matter in multiple sclerosis patients using multivoxel magnetic resonance spectroscopy imaging , 2017, Medicine.
[8] W. Bogner,et al. (2 + 1)D‐CAIPIRINHA accelerated MR spectroscopic imaging of the brain at 7T , 2016, Magnetic resonance in medicine.
[9] Bertrand Audoin,et al. Metabolic voxel‐based analysis of the complete human brain using fast 3D‐MRSI: Proof of concept in multiple sclerosis , 2016, Journal of magnetic resonance imaging : JMRI.
[10] Vinzenz Fleischer,et al. Metabolic Patterns in Chronic Multiple Sclerosis Lesions and Normal-appearing White Matter: Intraindividual Comparison by Using 2D MR Spectroscopic Imaging. , 2016, Radiology.
[11] Vinzenz Fleischer,et al. Changes and variability of proton density and T1 relaxation times in early multiple sclerosis: MRI markers of neuronal damage in the cerebral cortex , 2016, European Radiology.
[12] Wolfgang Bogner,et al. Mapping of brain macromolecules and their use for spectral processing of 1H-MRSI data with an ultra-short acquisition delay at 7T , 2015, NeuroImage.
[13] Susan A. Gauthier,et al. Measuring longitudinal myelin water fraction in new multiple sclerosis lesions , 2015, NeuroImage: Clinical.
[14] L. Kappos,et al. Magnetization transfer ratio in lesions rather than normal-appearing brain relates to disability in patients with multiple sclerosis , 2015, Journal of Neurology.
[15] J. Kurtzke. On the origin of EDSS. , 2015, Multiple sclerosis and related disorders.
[16] M. Lowe,et al. Identifying the Start of Multiple Sclerosis Injury: A Serial DTI Study , 2014, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[17] Jens Frahm,et al. Clinical proton MR spectroscopy in central nervous system disorders. , 2013, Radiology.
[18] Simon Hametner,et al. Iron and neurodegeneration in the multiple sclerosis brain , 2013, Annals of neurology.
[19] Margit Jehna,et al. Quantitative susceptibility mapping in multiple sclerosis. , 2013, Radiology.
[20] Rolf Gruetter,et al. Proton T1 relaxation times of metabolites in human occipital white and gray matter at 7 T , 2013, Magnetic resonance in medicine.
[21] Assaf Tal,et al. Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS , 2013, Neurology.
[22] Yan Li,et al. T1 and T2 Metabolite Relaxation Times in Normal Brain at 3T and 7T , 2013 .
[23] Reto Meuli,et al. MP2RAGE Multiple Sclerosis Magnetic Resonance Imaging at 3 T , 2012, Investigative radiology.
[24] Brian K. Rutt,et al. Deficient MWF mapping in multiple sclerosis using 3D whole-brain multi-component relaxation MRI , 2012, NeuroImage.
[25] Massimo Filippi,et al. MR imaging of multiple sclerosis. , 2011, Radiology.
[26] Jeffrey A. Cohen,et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.
[27] Helene Ratiney,et al. MR spectroscopic imaging of glutathione in the white and gray matter at 7 T with an application to multiple sclerosis. , 2010, Magnetic resonance imaging.
[28] Hans Lassmann,et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains , 2009, Brain : a journal of neurology.
[29] Y. Ge. Multiple sclerosis: the role of MR imaging. , 2006, AJNR. American journal of neuroradiology.
[30] A J Thompson,et al. Survey of the distribution of lesion size in multiple sclerosis: implication for the measurement of total lesion load , 1997, Journal of neurology, neurosurgery, and psychiatry.